Cliengo vs Nvecta: Revenue, Funding & Team Size Compared
Cliengo generates $7M in revenue; Nvecta generates $6.9M. Cliengo and Nvecta are close to the same size by revenue. The table below compares Cliengo and Nvecta on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  CliengoThis company |  Nvecta |
|---|---|---|
| Revenue | $7M | $6.9M |
| Valuation | $70.4M | Not disclosed |
| Team size | 72 | 63 |
| Founded | 2017 | 2011 |
| HQ | Buenos Aires, Argentina | Delhi, India |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Cliengo at a glance
Cliengo generates $7M in revenue with 72 employees, headquartered in Buenos Aires, Argentina.
- Revenue
- $7M
- Valuation
- $70.4M
- Team size
- 72
- Founded
- 2017
Cliengo impulsa las relaciones comerciales con tus clientes a través de una plataforma conversacional. Conversa con tus clientes 24/7 y triplica las tasas de conversión de tu sitio web. Chatbot, Live Chat, CRM, Inteligencia Artificial. Más…
Nvecta at a glance
Nvecta generates $6.9M in revenue with 63 employees, headquartered in Delhi, India.
- Revenue
- $6.9M
- Team size
- 63
- Founded
- 2011
Nvecta is an AI-powered marketing automation and CDP solution. It provides an omnichannel experience that helps you reach your desired audience through email, SMS, push notifications, pop-ups, and much more. With Nvecta, you can send…
Other Cliengo alternatives
Cliengo competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Cliengo vs Nvecta: frequently asked questions
Is Cliengo or Nvecta bigger?
Cliengo is the bigger company by revenue, at $7M against $6.9M for Nvecta.
How much revenue does Cliengo make?
Cliengo generates $7M in annual revenue with a team of 72.
How much revenue does Nvecta make?
Nvecta generates $6.9M in annual revenue with a team of 63.